Evaluation of the Rosa Chatbot Providing Genetic Information to Patients at Risk of Hereditary Breast and Ovarian Cancer: Qualitative Interview Study.BACKGROUND
 Therefore, we developed a chatbot app (Rosa) that is able to perform humanlike digital conversations about genetic BRCA testing.


 Overall, 175 healthy individuals at risk of hereditary breast and ovarian cancer were invited to test the chatbot, Rosa, before and after genetic counseling.  The semistructured interviews covered the following topics: usability, perceived usefulness, trust in the information received via the chatbot, how Rosa influenced the user, and thoughts about future use of digital tools in health care.  As Rosa was created by health care professionals, they also valued the information they received as being medically correct.  Rosa was referred to as being better than Google because it provided specific and reliable answers to their questions.  All participants (16/16) denied increased worry after reading about genetic testing and hereditary breast and ovarian cancer in Rosa.


 It was consistent across concepts that Rosa was a tool for preparation and repetition; however, none of the participants (0/16) supported that Rosa could replace genetic counseling if hereditary cancer was confirmed. 
Rosa
Rosa was referred to as being better than Google because it provided specific and reliable answers to their questions. 
Google